TNFSF13 and hematologic disorder: However, although BAFF and APRIL have been advanced as possible targets in non-hematologic malignancies [reviewed in Ryan and Grewal (131) and Rihacek et al. (119)], no systematic detection of APRIL–BAFF and their receptors has been performed in different cell lines and human tumors.